Page Image

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.

ESMO

Latest Episode

Episode 374: Mechanisms of HIF Resistance
Jim Brugarolas, MD, PhD, joins the podcast to discuss his talk from IKCS 2024 and the broad topic of resistance to HIF inhibitors. Dr. Brugarolas is the founding director of the Kidney Cancer Program at the Harold C. Simmons Comprehensive Cancer Center. ...
Advertisement
Advertisement

The Uromigos: Live and Unplugged 2023

Kidney Cancer Discussions

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics

Advertisement
Advertisement
Get updates from The Uromigos straight to your inbox.